Search research articles
Contact Us
Filters
Showing results (11-20 of 133) with videos related to
Page
of 14
Sort By:
Schizophrenia Research
|
July 11, 2017
Accelerated aging in schizophrenia and related disorders: Future research
Brian Kirkpatrick, Brian K Kennedy
Schizophrenia Bulletin
|
September 28, 2013
Inflammation and schizophrenia
Brian Kirkpatrick, Brian J Miller
NPJ Schizophrenia
|
October 25, 2017
Correspondence regarding two recent publications in npj:schizophrenia about DNAm and accelerated aging in schizophrenia
Emilio Fernandez-Egea, Brian Kirkpatrick
Spanish Journal of Psychiatry and Mental Health
|
April 9, 2024
Assessment and the concept of negative symptoms
Brian Kirkpatrick, Emilio Fernandez-Egea
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
November 27, 2013
Defining and measuring negative symptoms of schizophrenia in clinical trials
Stephen R Marder, Brian Kirkpatrick
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
March 28, 2024
Eli Robins: The grandfather of DSM-III
Brian Kirkpatrick, Emilio Fernandez-Egea
Schizophrenia Bulletin
|
June 3, 2017
Primary, Enduring Negative Symptoms: An Update on Research
Brian Kirkpatrick, Armida Mucci, Silvana Galderisi
Schizophrenia Research
|
February 12, 2008
Schizoid-like features and season of birth in a nonpatient sample
Brian Kirkpatrick, Erick Messias, David LaPorte
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
July 3, 2002
Glucocorticoid hormones and early brain development in schizophrenia
James I Koenig, Brian Kirkpatrick, Paul Lee
Schizophrenia Research
|
July 3, 2003
Substance abuse and the heterogeneity of schizophrenia a population-based study
Brian Kirkpatrick, Erick M Messias, Cenk Tek
Page
of 14
Search research articles
Search
Showing results (11-20 of 133) with videos related to
Sort By:
Page
of 14
Schizophrenia Research
|
July 11, 2017
Accelerated aging in schizophrenia and related disorders: Future research
Brian Kirkpatrick, Brian K Kennedy
Schizophrenia Bulletin
|
September 28, 2013
Inflammation and schizophrenia
Brian Kirkpatrick, Brian J Miller
NPJ Schizophrenia
|
October 25, 2017
Correspondence regarding two recent publications in npj:schizophrenia about DNAm and accelerated aging in schizophrenia
Emilio Fernandez-Egea, Brian Kirkpatrick
Spanish Journal of Psychiatry and Mental Health
|
April 9, 2024
Assessment and the concept of negative symptoms
Brian Kirkpatrick, Emilio Fernandez-Egea
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
November 27, 2013
Defining and measuring negative symptoms of schizophrenia in clinical trials
Stephen R Marder, Brian Kirkpatrick
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
March 28, 2024
Eli Robins: The grandfather of DSM-III
Brian Kirkpatrick, Emilio Fernandez-Egea
Schizophrenia Bulletin
|
June 3, 2017
Primary, Enduring Negative Symptoms: An Update on Research
Brian Kirkpatrick, Armida Mucci, Silvana Galderisi
Schizophrenia Research
|
February 12, 2008
Schizoid-like features and season of birth in a nonpatient sample
Brian Kirkpatrick, Erick Messias, David LaPorte
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
July 3, 2002
Glucocorticoid hormones and early brain development in schizophrenia
James I Koenig, Brian Kirkpatrick, Paul Lee
Schizophrenia Research
|
July 3, 2003
Substance abuse and the heterogeneity of schizophrenia a population-based study
Brian Kirkpatrick, Erick M Messias, Cenk Tek
Page
of 14